Scientific publications

Revisiting intracavitary immunotherapy of cancer

May 13, 2022 | Magazine: Clinical Cancer Research

Fernando Aranda  1 , Iñaki Eguren-Santamaria  2 , Angela Bella  1 , Pedro Berraondo  1 , Ignacio Melero  3


Ovarian cancer is often limited to the peritoneal cavity in the form of peritoneal carcinomatosis. Peritoneal spreading offers the opportunity for locoregional delivery of combinations of immunotherapy agents, maximizing bioavailability while potentially reducing systemic exposure and side effects.

CITATION  Clin Cancer Res. 2022 May 13;28(10):1993-1995.
doi: 10.1158/1078-0432.CCR-22-0201.